Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir Phase II Study in Japanese Adults with Chronic Hepatitis B
NCT01020565Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2003
- Primary completion
- Feb 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of entecavir in Chronic Hepatitis B (CHB), sponsored by Bristol Myers Squibb. Started Feb 2003; status: completed.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01020565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01020565.